By Rosemarie Szostak, Ph.D., Nerac Analyst
Originally published January 20, 2017
This sample report demonstrates technology scouting in the edible packaging market space.
Read More
The Regulatory Environment for 3D Printing in the Healthcare Field
By Erica Kramer,Ph.D., Nerac Analyst
Originally published January 19, 2017
Learn more about 3D printing in the medical field and and key conclusions on regulatory issues in the healthcare market.
Read More
Don’t Be Afraid — How to Quickly and Thoroughly Review a Patent
By Kevin Closson, M.A., Nerac Analyst
Originally published January 19, 2017
An overview of the most important elements of reviewing a patent.
Read More
Exciting Novel, but High-Cost Developments in Cancer Treatment: Immunotherapy continues to advance as a validated approach
By Holly Magna, Ph.D., Nerac Analyst
Originally published November 28, 2016
A review of some of the newly marketed therapies and some still in development, as well as their complications, risks and advantages
Read More
Graphene: Quest for the Killer App
By Rosemarie Szostak, Ph.D., Nerac Analyst
Originally published November 28, 2016
The hunt for the killer app for graphene is on!
Read More
Drug Safety Updates – Regulations and FDA Guidance for Industry
By Stephen Buxser, Ph.D., Nerac Analyst
Originally published November 28, 2016
For drugs licensed for sale in the United States, as well as elsewhere in the world, there are requirements for periodic literature updates/reviews. This article describes the legal requirements for drug safety and efficacy reporting.
Read More
Defining “Natural” in Food Labeling – Why does it matter?
By Helga Weires, Nerac Analyst
Originally published October 13, 2016
Defining the term “natural” has been a hot topic among the manufacturers, consumers and regulators of the food industry in recent years. The use of the term “natural” or “all natural” is ubiquitous on store shelves across the country, yet there has been confusion as to what this word really means in food labeling and advertising.
Read More
Patent Landscaping and Mount Everest: How to navigate a successful trip
By Tom Perkins, Nerac Analyst
Originally published October 13, 2016
This article compares some similarities to preparing and creating a successful patent portfolio using patent landscaping with reaching the summit of the world’s tallest peak.
Read More
Brexit: Implications on your Intellectual Property Rights
By Eden Joy Pacsial-Ong, Ph.D.
Originally published October 13, 2016
This article reviews some of the impacts of the British exit from EU, or Brexit, and the resulting uncertainty that surrounds the UK, its relationship with the EU, and the ultimate impact on trade, immigration and intellectual property (IP) laws.
Read More
Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A 3-Part Nerac Perspective
By Richard Conforti, M.S.
Originally published August 15, 2016
This is a 3-part series of articles on the 2014 Chinese Food and Drug Administration(CFDA), providing an update on their medical device regulations. The first article discussed which devices can be used to support your submission to the CFDA. The second article addressed the changes to selecting clinical literature. The third article describes the final clinical literature report.
Read all three here
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 20
- Next Page »